Entering text into the input field will update the search result below

$AZN : Will COVID Vaccine Development Propulse AstraZeneca?

Dec. 29, 2020 11:43 AM ETAstraZeneca PLC (AZN)
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

AstraZeneca is a British-Swedish multinational pharmaceutical and biopharmaceutical company. Founded in 1999 and headquartered in Cambridge, UK, it is a merger of the Swedish Astra AB and British Zeneca Group. Astrazeneca is a part of FTSE100 index. Investors can trade it under the ticker $AZN at London Stock Exchange and also under $AZN at NASDAQ. The company has a portfolio of products for such disease areas like cancer, gastrointestinal, cardiovascular, inflammation, respiratory and infection. Besides the engagegement in these areas, in recent weeks Astrazeneca has attracted a strong attention as one of the suppliers of vaccines to fight against COVID-19. Will this involvement promote the stock price to the new highs?

AstraZeneca Monthly Elliott Wave Analysis 12.28.2020

The monthly chart below shows the Astrazeneca stock $AZN traded at Nasdaq. From the all-time lows, the stock price is showing Elliott wave motive wave patterns. Firstly, the cycle up in black wave (I) of grand super cycle degree has ended by printing its top in September 2000 at 26.63. After 5 waves higher in (I), the correction lower in 3 swings of wave ((II)) lower has ended in September 2002 at 14.00.

Secondly, from the 2002 lows, a new motive cycle higher in black wave ((III)) is in progress. Hereby, the advance towards January 2020 highs at 51.55 is a leading diagonal structure within blue wave (I). To be noted: a sharp pullback of only 2 months towards March 2020 lows in wave (II) has corrected the entire cycle cycle higher of almost 18 years long. As a matter of fact, it has printed an important bottom at 36.15.

AstraZeneca Daily Elliott Wave Analysis 12.28.2020

The daily chart below shows in more detail the price action from the March 2020 lows at 36.15. First, an impulse within a wave I has ended in July 2002 at 64.94. Hereby, it has broken to the new all-time highs confirming the blue wave (III) to be in progress. From the top, a correction in wave II is unfolding as a double three structure. It should reach lower in 7 swings towards 42.90-39.30 area. From there, wave III of (III) should resume the rally to new highs.

Therefore, the blue box area 42.90-39.30 is a great opportunity to enter the market at a good price. Buyers should be waiting there. From the extremes, the AstraZeneca stock should accelerate in the red wave III towards 64.94 and higher or should bounce in 3 waves at least. The target for blue wave (III) will be 73.74-96.97 area.

Source: $AZN : Will COVID vaccine development propulse AstraZeneca?

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.